| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/02/2010 | US20100222256 Novel polypeptide anti-HIV agent containing the same |
| 09/02/2010 | US20100222255 Peptoid oligomers, pharmaceutical compositions and methods of using the same |
| 09/02/2010 | US20100222253 Methods for extracting platelets and compositions obtained therefrom |
| 09/02/2010 | US20100222252 Deshydroxy vancomycin, the preparation, pharmaceutical composition and the use |
| 09/02/2010 | US20100222250 Poly-beta-peptides from functionalized beta-lactam monomers and antibacterial compositions containing same |
| 09/02/2010 | US20100221822 Humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 09/02/2010 | US20100221367 Use of solidago virgaurea in the treatment and prevention of viral infections |
| 09/02/2010 | US20100221360 Silver-containing inorganic antibacterial |
| 09/02/2010 | US20100221359 Solid Compositions Containing Combinations of Lactoferrin, Colostrm, and Citrus Pectin |
| 09/02/2010 | US20100221358 Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic disorders |
| 09/02/2010 | US20100221357 Drug delivery product and methods |
| 09/02/2010 | US20100221349 Nucleic acid constructs |
| 09/02/2010 | US20100221331 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 09/02/2010 | US20100221328 Sustained-release formulations |
| 09/02/2010 | US20100221323 Crystal Entecavir Formulation And The Preparation Method Thereof |
| 09/02/2010 | US20100221305 Formulations for coated microprojections containing non-volatile counterions |
| 09/02/2010 | US20100221299 Therapeutic stem cell nutrient composition and uses thereof |
| 09/02/2010 | US20100221298 Novel galenical system for active transport, method for preparation and use |
| 09/02/2010 | US20100221288 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 09/02/2010 | US20100221287 Streptococcus pneumoniae Polynucleotides and Sequences |
| 09/02/2010 | US20100221286 Modified live aeromonas hydrophila vaccine for aquatic animals |
| 09/02/2010 | US20100221284 Novel vaccine composition |
| 09/02/2010 | US20100221283 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 09/02/2010 | US20100221281 High molecular weight polysaccharide that binds and inhibits virus |
| 09/02/2010 | US20100221280 Plant-produced compositions for treating papillomavirus infection and related methods |
| 09/02/2010 | US20100221279 Kennel cough vaccine |
| 09/02/2010 | US20100221278 Immunogenic compositions for streptococcus pyogenes |
| 09/02/2010 | US20100221277 Chlamydia pneumoniae antigens |
| 09/02/2010 | US20100221275 Protection of an animal against pestivirus infection |
| 09/02/2010 | US20100221273 Treatment of viral infections |
| 09/02/2010 | US20100221264 Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein |
| 09/02/2010 | US20100221259 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 09/02/2010 | US20100221257 Binding members-513 |
| 09/02/2010 | US20100221256 Meningococcus adhesins nada, app and orf 40 |
| 09/02/2010 | US20100221253 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 09/02/2010 | US20100221242 Anti-viral griffithsin compounds, compositions and methods of use |
| 09/02/2010 | US20100221241 Constrained hiv envelope-based immunogen that simultaneously presents receptor and coreceptor binding sites |
| 09/02/2010 | US20100221237 Enzyme disruption of bacterial biofilms |
| 09/02/2010 | US20100221227 Novel method of treating disease |
| 09/02/2010 | US20100221222 Interferons, uses and compositions related thereto |
| 09/02/2010 | US20100221221 N-phenyl-2-pyrimidineamine derivatives |
| 09/02/2010 | US20100221217 Therapeutic composition |
| 09/02/2010 | US20100221216 Hepatitis c virus inhibitors |
| 09/02/2010 | US20100221215 Linked dibenzimidazole derivatives |
| 09/02/2010 | US20100221214 Linked dibenzimidazole derivatives |
| 09/02/2010 | US20100221195 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| 09/02/2010 | US20100221179 IL-1 Binding Proteins |
| 09/02/2010 | DE112004002032B4 Concentricolid und seine Derivate, Verfahren zum Herstellen pharmazeutischer Zusammensetzungen umfassend deren Verwendung Concentricolid and its derivatives, method for preparing pharmaceutical compositions comprising the use of |
| 09/02/2010 | CA2753667A1 Amorphous salt of a macrocyclic inhibitor of hcv |
| 09/02/2010 | CA2751220A1 Combination of a nucleoside polymerase inhibitor with a macrocyclic protease inhibitor and use thereof in the treatment of hepatitis c, liver fibrosis and impaired liver function |
| 09/01/2010 | EP2223934A1 Methods for inhibiting influenza virus infection and their drugs |
| 09/01/2010 | EP2223933A1 Genes encoding major capsid protein l1 of human papilloma viruses |
| 09/01/2010 | EP2223927A2 Cyclic phosphonic acid based prodrugs of PMEA and its analogues |
| 09/01/2010 | EP2223926A1 Pyridine derivative substituted with heterocycle and phosphonoxymethyl group and antifungal agent containing the same |
| 09/01/2010 | EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/01/2010 | EP2222710A1 Recombinant rsv antigens |
| 09/01/2010 | EP2222672A1 3-aminosulfonyl substituted indole derivatives and methods of use thereof |
| 09/01/2010 | EP2222661A2 Non-nucleoside reverse transcriptase inhibitors |
| 09/01/2010 | EP2222648A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
| 09/01/2010 | EP2222646A1 Uracil or thymine derivative for treating hepatitis c |
| 09/01/2010 | EP2222641A1 A new inhibitor of dd-peptidase and its use as antibiotic or anticancer drug |
| 09/01/2010 | EP2222330A1 Treatment of inflammatory illnesses with ace2 |
| 09/01/2010 | EP2222324A2 Boceprevir derivatives for the treatment of hcv infections |
| 09/01/2010 | EP2222318A2 Anti-influenza viral composition containing bark or stem extract of alnus japonica |
| 09/01/2010 | EP2222317A1 Antimicrobial composition comprising an extract of a polyporaceae and a process for making the same |
| 09/01/2010 | EP2222309A1 Antibiotic macrocycle compounds and methods of manufacture and use thereof |
| 09/01/2010 | EP2222307A1 Use of amorolfine for treating a nail disease by iontophoresis |
| 09/01/2010 | EP2019825B1 Inhibitors of human immunodeficiency virus replication |
| 09/01/2010 | EP1709047B1 Azabenzofuran substituted thioureas as inhibitors of viral replication |
| 09/01/2010 | EP1469809B1 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same |
| 09/01/2010 | EP1451144B1 Compositions for treating acne comprising phytandiol amine |
| 09/01/2010 | EP1427815B1 Methods for the industrial production of vaccines |
| 09/01/2010 | EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 09/01/2010 | EP1337558B1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 09/01/2010 | EP1255543B1 Use of retinoid-type compounds as antibacterial agents against staphylococcus aureus |
| 09/01/2010 | CN1876103B Modified 'Shuang Huanglian' medicinal liquor for birds and preparation method thereof |
| 09/01/2010 | CN1565475B Product for prevention and treatment for virus infection of respiratory tract |
| 09/01/2010 | CN101821629A Method for predicting the response of subject suffering from viral infection of the liver to antiviral therapy |
| 09/01/2010 | CN101821390A Oligonucleotides for modulation of target RNA activity |
| 09/01/2010 | CN101821268A Tetracyclic compounds for the treatment of hepatitis c |
| 09/01/2010 | CN101821267A Compounds for the treatment of hepatitis c |
| 09/01/2010 | CN101821252A Substituted indole derivatives and methods of use thereof |
| 09/01/2010 | CN101820906A Cytomegalovirus vaccines and methods of production |
| 09/01/2010 | CN101820904A Method of eliciting an immune response against pandemic influenza virus |
| 09/01/2010 | CN101820877A Agent for fungal dermatitis |
| 09/01/2010 | CN101820872A Antimicrobial agent and external preparation for skin containing the same |
| 09/01/2010 | CN101820865A Improvements relating to anti-HIV tablet formulations |
| 09/01/2010 | CN101818185A Purification process for bacterial cytolysin |
| 09/01/2010 | CN101818163A Recombined adenovirus expressing Asia-1 foot-and-mouth disease virus VLP (Virus-like Particles) and application thereof |
| 09/01/2010 | CN101818162A Molecular design of IBDV (Infectious Bursal Disease Virus) antigen epitope and HBcAg (Hepatitis B Core Antigen) chimeric gene |
| 09/01/2010 | CN101818132A Construction of chimeric rabies strain rLEP333Q-L(H) and research on biological function thereof |
| 09/01/2010 | CN101818131A Production method for influenza virus vaccines |
| 09/01/2010 | CN101818130A gG and TK gene-deleted recombinant infectious bovine rhinotracheitis virus and application |
| 09/01/2010 | CN101817883A Housefly cecropin-human lysozyme fusion protein, and preparation method and application thereof |
| 09/01/2010 | CN101817871A Edwardsiella tarda quorum sensing blocking factor, construction and application thereof |
| 09/01/2010 | CN101817837A Carbapenem derivative containing azabicyclo |
| 09/01/2010 | CN101817834A Pyrazole derivatives and preparation method and application thereof |
| 09/01/2010 | CN101817820A Method for synthesizing moxifloxacin hydrochloride |
| 09/01/2010 | CN101817817A Rare earth metal complexes using orbifloxacin as ligand, method for synthesizing same and application thereof |
| 09/01/2010 | CN101817805A Andrographolide derivative and preparation method and application thereof |